Virscio
Christopher Stanley has extensive experience in business development and finance, currently serving as Chief Business Officer and Co-founder at Virscio since 2003. In addition, Christopher is a Co-Founder and Director at Exhaura, Ltd., a position held since 2018. Prior experience includes a role as a Specialist in Corporate Transaction Services at Accenture from 1999 to 2002, where responsibilities encompassed due diligence, financial modeling, and investment evaluation. Additionally, Christopher worked as an Analyst in Global Markets at JPMorgan Chase from 1997 to 1999. Educationally, Christopher holds a BBA in Finance from the Texas McCombs School of Business.
This person is not in any teams
This person is not in any offices
Virscio
1 followers
Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.